Advertisement

Pharmacy

Amid a shortage, drug prices increase at roughly twice their usual rate, suggesting that pharma companies may be exploiting drug shortages to increase profits, according to a new study published in the Annals of Internal Medicine.

In an effort to save its reputation from the hit it took earlier this year, Swiss pharmaceutical giant Novartis revealed its employees will only get bonuses if they meet or exceed expectations for ethical behavior, according to Reuters.

The FDA found a second toxin that may cause cancer in three lots of valsartan, a commonly prescribed drug to control blood pressure and prevent heart failure.

Advertisement
Advertisement